KRAS and lung carcinoma: However, when crossed with mice expressing mutant KRAS in the lung, NSCLC tumors developed [111], clearly demonstrating that oncogenic mutants of VAV1 act synergistically with mutant KRAS to cause lung cancer (Figure 5).